World Wires · story 17254 · official · 1 source(s)

SCHEDULE 13D: Orbimed Advisors Llc discloses a stake in ADARx Pharmaceuticals, Inc.

Filed: 2026-10-02 AccNo: 0000947871-26-000917 Size: 42 KB

Open in the desk

Coverage

• SCHEDULE 13D: Orbimed Advisors Llc discloses a stake in ADARx Pharmaceuticals, Inc. SEC EDGAR: Schedule 13D stakes · tier A · clear net · 2026-10-02 21:36 UTC

What this site indexes